REG - Feedback PLC - Bleepa TB Screening Pilot Now Live in Odisha

FeedbackAnnouncement

31/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220331:nRSe6695Ga&default-theme=true

RNS Number : 6695G  Feedback PLC  31 March 2022

 

Feedback plc

 

 

Bleepa TB Screening Pilot Now Live in Odisha

 

·     The 1(st) patient has gone through Bleepa's cloud-based TB
screening pathway at the Evangelical Hospital Khariar, India.

·     The live pilot enables real-world illustration of Bleepa's
capabilities and will strengthen further commercial and partnership
discussions in India.

 

London, 31 March 2022: Feedback plc (AIM: FDBK, "Feedback" or the "Company"),
the specialist clinical communication company, announces that its cloud TB
screening service is now live at the Evangelical Hospital Khariar in Odisha,
India.

 

The service sees digital X-rays securely transmitted via mobile networks to
the cloud where the images are analysed by Feedback's partner Qure.ai, before
being shared with clinicians. Using Bleepa's pioneering capabilities a
screening result can be available within minutes of an X-ray being acquired,
almost anywhere in India.

 

The impact of this technology means that TB screening can now be expanded to
rural areas where digital imaging was difficult to deliver. This enables
current TB screening services to reach more people and grow the number of
their existing screening contracts.

 

The pilot, run in partnership with Qure.ai and Amazon Web Services will now
move into an evaluative stage where the system benefits will be measured as
patients come through. In parallel the Company will pursue a number of
opportunities to commercialise the system, leveraging the evidence generated
by the pilot.

 

Annual India Radiological & Imaging Association Conference

Feedback was delighted to attend the 74th Annual India Radiological &
Imaging Association conference (IRIA 2022), bringing together thousands of
India's top radiologists and specialists earlier this month. Feedback's Chief
Marketing and Sales Officer Nick Mayhew joined a panel discussion on Global
Radiology Innovations while the Company debuted Bleepa, BleepaBox and
CareLocker.

 

Dr Tom Oakley, CEO of Feedback, said: "This is a great milestone for the
Company, opening the gateway to a significant market and the opportunity to
transform care for a great many people.

 

"India has made massive strides in the development and adoption of medical
technology to support the diagnosis and treatment of diseases. We support
India's vision to eliminate TB by 2025, five years ahead of the UN's SDG
goals, and believe that we can make a significant contribution to help India
reach this goal.  We are confident that our pilot programme will demonstrate
the value of Bleepa to rapidly screen for TB, particularly in remote,
resource-scarce locations where this has been a challenge."

 

 

Further information on Feedback and its products can be found on the Company's
website: https://fbkmed.com/feedback-plc/reports-and-presentations/
(https://fbkmed.com/feedback-plc/reports-and-presentations/)

 

-Ends-

 

Enquiries:

 

 Feedback plc                                    +44 (0) 20 3997 7634

 Tom Oakley, CEO                                 IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Gordon (UK) Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd                                 Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                 (mailto:feedbackplc@walbrookpr.com)
 Paul McManus/Nick Rome/Nicholas Johnson         07980 541 893 or 07748 325 236 or 07884 664 686

 

 

About Feedback

 

Feedback plc is a specialist clinical communications business, with a mission
to improve the efficiency and quality of communications for frontline
clinicians and hospitals with a key focus on building solutions that enhance
access to high quality patient data.

 

Feedback has developed a toolkit of clinical communications apps. Its core,
regulatory approved product is Bleepa, a revolutionary medical imaging app
enabling remote and secure communications between frontline clinicians and
teams. CareLocker is an evolutionary GDPR compliant patient-centric cloud
architecture - its proprietary technology enables an easy route to creation
and mobilisation of individual healthcare records. Bleepa Box is a specialist
tool to enable image transfer from remote settings to the Bleepa platform over
mobile networks.

 

The Company has a number of growth opportunities domestically and
internationally across a range of markets including the NHS, the veterinary
market and private healthcare providers and its highly scalable Software as a
Service ("SaaS")-based revenue model is expected to provide increasing levels
of visibility as the Company grows its customer base.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBRGDXUGXDGDG